AQR Capital Management’s Calithera Biosciences, Inc CALA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-686
| Closed | -$33K | – | 2327 |
|
|
2021
Q1 | $33K | Sell |
686
-3,224
| -82% | -$155K | ﹤0.01% | 2177 |
|
|
2020
Q4 | $384K | Sell |
3,910
-2,592
| -40% | -$255K | ﹤0.01% | 1877 |
|
|
2020
Q3 | $449K | Sell |
6,502
-2,104
| -24% | -$145K | ﹤0.01% | 1773 |
|
|
2020
Q2 | $909K | Buy |
8,606
+2,991
| +53% | +$316K | ﹤0.01% | 1497 |
|
|
2020
Q1 | $499K | Buy |
5,615
+3,917
| +231% | +$348K | ﹤0.01% | 1586 |
|
|
2019
Q4 | $194K | Buy |
+1,698
| New | +$194K | ﹤0.01% | 2015 |
|
|
2019
Q3 | – | Sell |
-1,086
| Closed | -$85K | – | 2194 |
|
|
2019
Q2 | $85K | Sell |
1,086
-1,310
| -55% | -$103K | ﹤0.01% | 2040 |
|
|
2019
Q1 | $323K | Sell |
2,396
-847
| -26% | -$114K | ﹤0.01% | 1946 |
|
|
2018
Q4 | $260K | Sell |
3,243
-523
| -14% | -$41.9K | ﹤0.01% | 2006 |
|
|
2018
Q3 | $395K | Sell |
3,766
-2,796
| -43% | -$293K | ﹤0.01% | 2022 |
|
|
2018
Q2 | $656K | Sell |
6,562
-24,498
| -79% | -$2.45M | ﹤0.01% | 1888 |
|
|
2018
Q1 | $3.91M | Sell |
31,060
-5,842
| -16% | -$736K | ﹤0.01% | 1092 |
|
|
2017
Q4 | $6.16M | Buy |
36,902
+12,088
| +49% | +$2.02M | 0.01% | 946 |
|
|
2017
Q3 | $7.82M | Buy |
24,814
+23,056
| +1,311% | +$7.26M | 0.01% | 867 |
|
|
2017
Q2 | $522K | Buy |
+1,758
| New | +$522K | ﹤0.01% | 1872 |
|
|
2016
Q3 | – | Sell |
-1,220
| Closed | -$90K | – | 2309 |
|
|
2016
Q2 | $90K | Sell |
1,220
-1,876
| -61% | -$138K | ﹤0.01% | 2171 |
|
|
2016
Q1 | $352K | Buy |
3,096
+1,878
| +154% | +$214K | ﹤0.01% | 1950 |
|
|
2015
Q4 | $187K | Buy |
+1,218
| New | +$187K | ﹤0.01% | 2164 |
|